- Sanofi successfully switches Allegra
- GSK announces divestment of OTC brands
- Fourth annual Retail Clinician Education Congress brings together retail healthcare professionals
- McKesson to amplify independent pharmacies' healthcare delivery role
- Opening of Intel's on-site medical center officially announced by Take Care
SPRINGFIELD, Ill. — H. D. Smith, one of the nation’s largest pharmaceutical wholesalers, on Monday named Timothy Booth to corporate VP and head of its home healthcare division. Booth will report to Christopher Smith, H. D. Smith's president and COO.
“One of the nation’s important healthcare trends is the shift of patients from hospitals to home where they can advance their rehabilitation and wellness," stated Dale Smith, H. D. Smith chairman and CEO. "Meeting our customers’ and patients’ needs requires granular ability to ensure health products reach those in need to advance their care. … Timothy Booth’s success in managing businesses across multiple health product sectors, and commitment to improving the patient experience and supporting patient care, will enhance our industry-leading customer service and further bolster our HHC offerings.”
Booth brings to H. D. Smith nearly 20 years of expertise in the pharmaceutical manufacturing, packaging and distribution industries as a corporate executive and counselor. Most recently, he was an independent consultant providing guidance to companies in pharmaceutical industry strategy, operations, operating metrics, product pricing mechanisms and technical and regulatory information; prior to that role, he was president and CEO of PrePak Holdings, a pharmaceutical and consumer care contract packaging company based in Cookeville, Tenn. He also served as president of McKesson’s RxPak division, where he increased division revenue from $625 million to $1.2 billion, H. D. Smith reported.
Booth earned his bachelor's and Master of Business Administration from Cleveland State University.